Benign prostatic hyperplasia: Cost and effectiveness of three alternative surgical treatment methods used in a Turkish hospital

被引:1
|
作者
Agirbas I. [1 ]
Tatar M. [2 ]
Kisa A. [3 ]
机构
[1] Department of Health Administration, School of Health Education, Ankara University, Kecioren, Ankara
[2] School of Health Administration, Hacettepe University, Ankara
[3] Department of Health Administration, Baskent University, School of Health Sciences, 06530, Ankara
关键词
Benign prostatic hyperplasia; Cost effectiveness; Laser prostatectomy; Open prostatectomy; TURP;
D O I
10.1007/s10916-005-6105-5
中图分类号
学科分类号
摘要
The purpose of this study was to compare three alternative surgical therapies for Benign prostatic hyperplasia (BPH) in terms of their cost and effectiveness in a general hospital setting in Turkey. BPH is an important potential burden on health care resources in developing countries like Turkey, not only because of the increasing incidence of the disease, but also because of the differences in cost and effectiveness that exist among the various available treatment technologies. In this study, three alternative surgical treatments for BPH, namely open prostatectomy, transurethral resection of the prostate (TURP), and laser prostatectomy were compared in terms of their cost and effectiveness. Effectiveness was measured through the use of the International Prostate Symptom Score (IPSS) before the operation and at 3 months after. Laser prostatectomy was found to be the most costly and least effective way of treating BPH. This conclusion was valid both in terms of cost per prostate symptom score and cost per improvement of quality of life index. This study shows how a rough estimate can be made of the potential burdens that alternative treatment methods would impose on a country's health budget. © 2005 Springer Science+Business Media, Inc.
引用
收藏
页码:487 / 492
页数:5
相关论文
共 50 条
  • [31] Monopolar and bipolar transurethral prostate resection in surgical treatment of benign prostatic hyperplasia
    Hasirci, Eray
    Dirim, Ayhan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (04): : 265 - 269
  • [32] BENIGN PROSTATIC HYPERPLASIA - SURGICAL VERSUS NONSURGICAL TREATMENT - A CRITICAL-REVIEW
    BOCCONGIBOD, L
    EUROPEAN UROLOGY, 1991, 20 : 59 - 62
  • [33] The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia
    Yuksel, Alpaslan
    Tekin, Ali
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2016, 15 (03): : 119 - 122
  • [34] Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
    Ulchaker, James C.
    Martinson, Melissa S.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 29 - 43
  • [35] Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study
    Kim, Bum Soo
    Ko, Young Hwii
    Song, Phil Hyun
    Kim, Tae-Hwan
    Kim, Ki Ho
    Kim, Byung Hoon
    PROSTATE INTERNATIONAL, 2019, 7 (01) : 30 - 34
  • [36] Will Aquablation Be the New Benchmark for Robotic Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia?
    Nedbal, Carlotta
    Castellani, Daniele
    De Stefano, Virgilio
    Giulioni, Carlo
    Nicoletti, Rossella
    Pirola, Giacomo
    Teoh, Jeremy Yuen-Chun
    Elterman, Dean
    Somani, Bhaskar Kumar
    Gauhar, Vineet
    EUROPEAN UROLOGY FOCUS, 2024, 10 (04): : 581 - 593
  • [37] Can surgical treatment for benign prostatic hyperplasia improve sexual function? A systematic review
    Soans, Julian
    Vazirian-Zadeh, Mahmood
    Kum, Francesca
    Dhariwal, Randeep
    Breish, Mohamed Omran
    Singh, Sohail
    Mahmalji, Wasim
    Katmawi-Sabbagh, Samer
    AGING MALE, 2020, 23 (05) : 770 - 779
  • [38] Impact of benign prostatic hyperplasia surgical treatment on voiding and urinary bladder filling symptoms
    Milicevic, Snjezana
    Vasic, Dusko
    VOJNOSANITETSKI PREGLED, 2010, 67 (01) : 55 - 58
  • [39] Cost-Effectiveness of the Combination Therapy of Dutasteride and Tamsulosin in the Treatment of Benign Prostatic Hyperlasia in Spain
    Antonanzas, F.
    Brenes, F.
    Molero, J. M.
    Fernandez-Pro, A.
    Huerta, A.
    Palencia, R.
    Cozar, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (02): : 65 - 71
  • [40] Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial
    Johansen, Truls E. Bjerklund
    Baker, Timothy M.
    Black, Libby K.
    BJU INTERNATIONAL, 2012, 109 (05) : 731 - 738